Tyra Biosciences, Inc.TYRANASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+30.1%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | +23.6% |
| 2024 | 0.02 | -43.0% |
| 2023 | 0.03 | +212.7% |
| 2022 | 0.01 | +159.4% |
| 2021 | 0.00 | +137.7% |
| 2020 | -0.01 | +80.5% |
| 2019 | -0.05 | - |